Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00901316 · ClinicalTrials.gov registry record · NA

Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in Children

A NA study, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
987
Enrollment target

NCT00901316: Completed NA study, sponsored by Baylor College of Medicine.

NCT00901316 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 987 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00901316, a NA study, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
987 participants
Enrollment target

Study Summary

The primary purpose of this study is to determine if adding bleach baths to routine ways for prevention of Staph infections is helpful. The amount added is a very weak amount. This would provide a relatively inexpensive method to help prevent recurrent skin infections caused by the Staph germ. The investigators will also be studying how often Staphylococcus aureus lives in the nose, throat, and groin area.

Primary Outcome

Medically attended skin and soft tissue infections (MA-SSI) which is defined as a skin or soft tissue infection that has been evaluated and treated by a medical professional in an office, clinic, urgent care or emergency center setting.

Interventions

  • PROCEDURE Routine Measures Group
  • PROCEDURE Bleach Bath Group (Bleach plus routine measures)

Trial Details

FieldValue
Enrollment Target 987 participants
Start Date 2009-06
Est. Completion 2013-01
Phase NA
Baylor College of Medicine

616 total trials

What the finished NCT00901316 record still lists

NCT00901316 is an interventional study that assigns participants to a tested intervention. The registered 987 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower).

The record links to 0 conditions, and to 2 interventions - of which Routine Measures Group is the first listed.

NCT00901316 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00901316 about?

NCT00901316 is a clinical study titled "Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in Children". The primary purpose of this study is to determine if adding bleach baths to routine ways for prevention of Staph infections is helpful. The amount added is a very weak amount. This would provide a relatively inexpensive method to help prevent recurrent skin infections caused by the Staph germ. The i...

What is the current status of trial NCT00901316?

This trial is currently completed. It is a NA study. The enrollment target is 987 participants. The study started on 2009-06. Estimated completion is 2013-01.

What interventions are being tested in trial NCT00901316?

The interventions under investigation include: Routine Measures Group (PROCEDURE), Bleach Bath Group (Bleach plus routine measures) (PROCEDURE).

Who is sponsoring clinical trial NCT00901316?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00901316's enrollment target sits among peer trials

987 122nd of 2000 higher than 1,879 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05079841 · 988 participants · Phase 4

    The Stimulation To Induce Mothers Study

  • NCT05441709 · 990 participants · NA

    Furthering Equity Through Infant Feeding EDucation and Support

  • NCT06340646 · 990 participants · NA

    Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

  • NCT06878261 · 990 participants · Phase 3

    A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00901316, the US trial registry maintained by the National Library of Medicine. NCT00901316 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.